• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胶原酶1抑制剂的高通量筛选

High-throughput screening for human collagenase 1 inhibitors.

作者信息

Ye Q Z, Nan F J, Hu L Y, Qian Z, Qian J

机构信息

National Centers for Drug Screening, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

出版信息

Acta Pharmacol Sin. 2000 Nov;21(11):1021-6.

PMID:11501057
Abstract

AIM

To establish a high-throughput method for inhibitor screening using a recombinant collagenase catalytic domain.

METHODS

Human collagenase 1 catalytic domain protein was expressed in E coli and used for screening a set of 2720 compounds in a high-throughput fashion.

RESULTS

The screening was accomplished within 2 h and 10 min with consumption of each compound at 4 micrograms. Sixty-six compounds were identified with > 60% inhibitory activity at 20 mg/L, among which 44 compounds were confirmed by subsequent testing at multiple concentrations. The most potent compound showed an IC50 at 4.3 mumol/L, and there were total 15 compounds with IC50 less than 20 mumol/L.

CONCLUSION

The high-throughput method using the recombinant collagenase is fast, effective and practical in identifying inhibitors.

摘要

目的

建立一种使用重组胶原酶催化结构域进行抑制剂筛选的高通量方法。

方法

人胶原酶1催化结构域蛋白在大肠杆菌中表达,并用于高通量筛选一组2720种化合物。

结果

筛选在2小时10分钟内完成,每种化合物的消耗量为4微克。鉴定出66种在20毫克/升时具有>60%抑制活性的化合物,其中44种化合物通过后续多浓度测试得到确认。最有效的化合物的IC50为4.3微摩尔/升,共有15种化合物的IC50小于20微摩尔/升。

结论

使用重组胶原酶的高通量方法在鉴定抑制剂方面快速、有效且实用。

相似文献

1
High-throughput screening for human collagenase 1 inhibitors.人胶原酶1抑制剂的高通量筛选
Acta Pharmacol Sin. 2000 Nov;21(11):1021-6.
2
Expression and purification of catalytic domain of human macrophage elastase for high throughput inhibitor screening.用于高通量抑制剂筛选的人巨噬细胞弹性蛋白酶催化结构域的表达与纯化
Acta Pharmacol Sin. 2002 Feb;23(2):143-51.
3
Development of a K562 cell-based assay for screening anticancer agents.
Acta Pharmacol Sin. 2001 Sep;22(9):821-6.
4
[High-throughput screening of human soluble epoxide hydrolase inhibitors].[人可溶性环氧化物水解酶抑制剂的高通量筛选]
Yao Xue Xue Bao. 2010 Nov;45(11):1367-72.
5
[High-throughput screening of human soluble protein tyrosine phosphatase 1B inhibitors].[人可溶性蛋白酪氨酸磷酸酶1B抑制剂的高通量筛选]
Yao Xue Xue Bao. 2011 Sep;46(9):1058-64.
6
A new screening method based on yeast-expressed human dipeptidyl peptidase IV and discovery of novel inhibitors.基于酵母表达的人二肽基肽酶IV的新型筛选方法及新型抑制剂的发现
Biotechnol Lett. 2009 Jul;31(7):979-84. doi: 10.1007/s10529-009-9963-y. Epub 2009 Mar 8.
7
A new model for random screening inhibitors of vascular endothelial growth factor receptor 1 kinase.一种用于随机筛选血管内皮生长因子受体1激酶抑制剂的新模型。
Acta Pharmacol Sin. 2002 Feb;23(2):117-23.
8
A high-throughput model for screening anti-tumor agents capable of promoting polymerization of tubulin in vitro.一种用于体外筛选能够促进微管蛋白聚合的抗肿瘤药物的高通量模型。
Acta Pharmacol Sin. 2004 Jun;25(6):775-82.
9
[High throughput screening for glutathione S-transferase inhibitors].[谷胱甘肽S-转移酶抑制剂的高通量筛选]
Yao Xue Xue Bao. 2008 Jan;43(1):108-12.
10
A complete system for identifying inhibitors of creatine kinase B.一种用于鉴定肌酸激酶B抑制剂的完整系统。
Anal Biochem. 2000 Mar 1;279(1):96-9. doi: 10.1006/abio.1999.4449.